NCT00551694View on ClinicalTrials.gov

A Second Study to Determine the Effect of GSK256073A on HVTs

PHASE1CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Healthy SubjectsDyslipidaemias

Interventions

DRUG

GSK256073A tablets

Trial Locations (1)

55404

GSK Investigational Site, Minneapolis

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY